A small compound that inhibits tumor necrosis factor-α-induced matrix metalloproteinase-9 upregulation

Biochemical and Biophysical Research Communications

Volumn 336, Issue 2, 2005, Pages 716-722

  Lee, Ha Young ^a   Kyoung, Sun Park ^a   Kim, Mi Kyoung ^a   Lee, Taehoon ^b   Sung, Ho Ryu ^c   Kyung, Jin Woo ^d   Taeg, Kyu Kwon ^d   Bae, Yoe Sik ^a  

^a Dong A University   (South Korea)

^b Sigmol Incorporation   (South Korea)

^c Pohang University of Science and Technology (POSTECH)   (South Korea)

^d Keimyung University   (South Korea)

Author keywords

Invasion; Matrix metalloproteinase 9; NF B; Small compound; TNF

Indexed keywords

ENZYME INHIBITOR; GELATINASE B; MESSENGER RNA; SM 7368; TRANSCRIPTION FACTOR AP 1; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ARTICLE; CELL LINE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DRUG EFFECT; FIBROSARCOMA; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION;

BENZAMIDES; CELL LINE, TUMOR; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; ENZYME ACTIVATION; FIBROSARCOMA; HUMANS; MATRIX METALLOPROTEINASE 9; MOLECULAR WEIGHT; NF-KAPPA B; THIAZOLES; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION;

EID: 24644504858     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2005.08.154     Document Type: Article

References (32)

1. N.D. Rawlings, and A.J. Barrett Evolutionary families of metallopeptidases Methods Enzymol. 248 1995 183 228
2. C.E. Brinckerhoff Joint destruction in arthritis: metalloproteinases in the spotlight Arthritis Rheum. 34 1991 1073 1075
3. P.P. Tak, and B. Bresnihan The pathogenesis and prevention of joint damage in rheumatoid arthritis: advances from synovial biopsy and tissue analysis Arthritis Rheum. 43 2000 2619 2633
4. A.J. Docherty, J. O'Connell, T. Crabbe, S. Angal, and G. Murphy The matrix metalloproteinases and their natural inhibitors: prospects for treating degenerative tissue diseases Trends Biotechnol. 10 1992 200 207
5. H. Birkedal-Hansen, W.G. Moore, M.K. Bodden, L.J. Windsor, B. Birkedal-Hansen, A. DeCarlo, and J.A. Engler Matrix metalloproteinases: a review Crit. Rev. Oral Biol. Med. 4 1993 197 250
6. S. Chandler, K.M. Miller, J.M. Clements, J. Lury, D. Corkill, D.C. Anthony, S.E. Adams, and A.J. Gearing Matrix metalloproteinases, tumor necrosis factor and multiple sclerosis: an overview J. Neuroimmunol. 72 1997 155 161
7. Z. Ma, H. Qin, and E.N. Benveniste Transcriptional suppression of matrix metalloproteinase-9 gene expression by IFN-gamma and IFN-beta: critical role of STAT-1alpha J. Immunol. 167 2001 5150 5159
8. Y. Ogata, M.A. Pratta, H. Nagase, and E.C. Arner Matrix metalloproteinase 9 (92-kDa gelatinase/type IV collagenase) is induced in rabbit articular chondrocytes by cotreatment with interleukin 1 beta and a protein kinase C activator Exp. Cell Res. 201 1992 245 249
9. P. Friedl, and K. Wolf Tumour-cell invasion and migration: diversity and escape mechanisms Nat. Rev. Cancer 3 2003 362 374
10. C. Ries, H. Kolb, and P.E. Petrides Regulation of 92-kD gelatinase release in HL-60 leukemia cells: tumor necrosis factor-alpha as an autocrine stimulus for basal- and phorbol ester-induced secretion Blood 83 1994 3638 3646
11. B. Zhang, G. Salituro, D. Szalkowski, Z. Li, Y. Zhang, I. Royo, D. Vilella, M.T. Diez, F. Pelaez, C. Ruby, R.L. Kendall, X. Mao, P. Griffin, J. Calaycay, J.R. Zierath, J.V. Heck, R.G. Smith, and D.E. Moller Discovery of a small molecule insulin mimetic with antidiabetic activity in mice Science 284 1999 974 977
12. S.S. Tian, P. Lamb, A.G. King, S.G. Miller, L. Kessler, J.I. Luengo, L. Averill, R.K. Johnson, J.G. Gleason, L.M. Pelus, S.B. Dillon, and J. Rosen A small, nonpeptidyl mimic of granulocyte-colony-stimulating factor Science 281 1998 257 259
13. G.R. Rosania, J. Merlie Jr., N. Gray, Y.T. Chang, P.G. Schultz, and R. Heald A cyclin-dependent kinase inhibitor inducing cancer cell differentiation: biochemical identification using Xenopus egg extracts Proc. Natl. Acad. Sci. USA 96 1999 4797 4802
14. Y.S. Bae, T.G. Lee, J.C. Park, J.H. Hur, Y. Kim, K. Heo, J.Y. Kwak, P.G. Suh, and S.H. Ryu Identification of a compound that directly stimulates phospholipase C activity Mol. Pharmacol. 63 2003 1043 1050
15. Y.A. Choi, H.K. Lim, J.R. Kim, C.H. Lee, Y.J. Kim, S.S. Kang, and S.H. Baek Group IB secretory phospholipase A2 promotes matrix metalloproteinase-2- mediated cell migration via the phosphatidylinositol 3-kinase and Akt pathway J. Biol. Chem. 279 2004 36579 36585
16. J.H. Woo, J.W. Park, S.H. Lee, Y.H. Kim, I.K. Lee, E. Gabrielson, S.H. Lee, H.J. Lee, Y.H. Kho, and T.K. Kwon Dykellic acid inhibits phorbol myristate acetate-induced matrix metalloproteinase-9 expression by inhibiting nuclear factor kappa B transcriptional activity Cancer Res. 63 2003 3430 3434
17. Y. Itoh, A. Takamura, N. Ito, Y. Maru, H. Sato, N. Suenaga, T. Aoki, and M. Seiki Homophilic complex formation of MT1-MMP facilitates proMMP-2 activation on the cell surface and promotes tumor cell invasion EMBO J. 20 2001 4782 4793
18. Y.P. Li, Y. Chen, J. John, J. Moylan, B. Jin, D.L. Mann, and M.B. Reid TNF-alpha acts via p38 MAPK to stimulate expression of the ubiquitin ligase atrogin1/MAFbx in skeletal muscle FASEB J. 19 2005 362 370
19. D. Brancho, N. Tanaka, A. Jaeschke, J.J. Ventura, N. Kelkar, Y. Tanaka, M. Kyuuma, T. Takeshita, R.A. Flavell, and J. Davis Mechanism of p38 MAP kinase activation in vivo Genes Dev. 17 2003 1969 1978
20. M. Bond, R.P. Fabunmi, A.H. Baker, and A.C. Newby Synergistic upregulation of metalloproteinase-9 by growth factors and inflammatory cytokines: an absolute requirement for transcription factor NF-kappa B FEBS Lett. 435 1998 29 34
21. C.H. Woo, J.H. Lim, and J.H. Kim Lipopolysaccharide induces matrix metalloproteinase-9 expression via a mitochondrial reactive oxygen species-p38 kinase-activator protein-1 pathway in Raw 264.7 cells J. Immunol. 173 2004 6973 6980
22. L.M. Coussens, and Z. Werb Inflammation and cancer Nature 420 2002 860 867
23. L.M. Coussens, and Z. Werb Inflammatory cells and cancer: think different! J. Exp. Med. 193 2001 F23 F26
24. R.J. Moore, D.M. Owens, G. Stamp, C. Arnott, F. Burke, N. East, H. Holdsworth, L. Turner, B. Rollins, M. Pasparakis, G. Kollias, and F. Balkwill Mice deficient in tumor necrosis factor-alpha are resistant to skin carcinogenesis Nat. Med. 5 1999 828 831
25. M. Suganuma, S. Okabe, M.W. Marino, A. Sakai, E. Sueoka, and H. Fujiki Essential role of tumor necrosis factor alpha (TNF-alpha) in tumor promotion as revealed by TNF-alpha-deficient mice Cancer Res. 59 1999 4516 4518
26. P. Orosz, B. Echtenacher, W. Falk, J. Ruschoff, D. Weber, and D.N. Mannel Enhancement of experimental metastasis by tumor necrosis factor J. Exp. Med. 177 1993 1391 1398
27. S.T. Malik, M.S. Naylor, N. East, A. Oliff, and F.R. Balkwill Cells secreting tumor necrosis factor show enhanced metastasis in nude mice Eur. J. Cancer 26 1990 1031 1034
28. M. Egeblad, and Z. Werb New functions for the matrix metalloproteinases in cancer progression Nat. Rev. Cancer 2 2002 161 174
29. H. Watanabe, I. Nakanishi, K. Yamashita, T. Hayakawa, and Y. Okada Matrix metalloproteinase-9 (92 kDa gelatinase/type IV collagenase) from U937 monoblastoid cells: correlation with cellular invasion J. Cell Sci. 104 1993 991 999
30. H. Sato, and M. Seiki Regulatory mechanism of 92 kDa type IV collagenase gene expression which is associated with invasiveness of tumor cells Oncogene 8 1993 395 405
31. M.A. Lauricella-Lefebvre, V. Castronovo, H. Sato, M. Seiki, D.L. French, and M.P. Merville Stimulation of the 92-kD type IV collagenase promoter and enzyme expression in human melanoma cells Invasion Metastasis 13 1993 289 300
32. G. Chen, and D.V. Goeddel TNF-R1 signaling: a beautiful pathway Science 296 2002 1634 1635